First Time Loading...

Edwards Lifesciences Corp
NYSE:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
NYSE:EW
Watchlist
Price: 84.7 USD -2.33% Market Closed
Updated: May 14, 2024

Operating Margin
Edwards Lifesciences Corp

28.7%
Current
32%
Average
4.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
28.7%
=
Operating Profit
1.8B
/
Revenue
6.1B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Edwards Lifesciences Corp
NYSE:EW
51B USD
29%
US
Abbott Laboratories
NYSE:ABT
182.3B USD
16%
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.1B USD
25%
US
Stryker Corp
NYSE:SYK
123.6B USD
21%
IE
Medtronic PLC
NYSE:MDT
111.1B USD
20%
US
Boston Scientific Corp
NYSE:BSX
107B USD
17%
US
Becton Dickinson and Co
NYSE:BDX
68.5B USD
11%
DE
Siemens Healthineers AG
XETRA:SHL
58.9B EUR
10%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
371.2B CNY
35%
US
Dexcom Inc
NASDAQ:DXCM
49.5B USD
17%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.7B USD
30%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 51B USD
Operating Margin
29%
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 182.3B USD
Operating Margin
16%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 135.1B USD
Operating Margin
25%
Stryker Corp
NYSE:SYK
Country US
Market Cap 123.6B USD
Operating Margin
21%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 111.1B USD
Operating Margin
20%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 107B USD
Operating Margin
17%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 68.5B USD
Operating Margin
11%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 58.9B EUR
Operating Margin
10%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 371.2B CNY
Operating Margin
35%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 49.5B USD
Operating Margin
17%
IDEXX Laboratories Inc
NASDAQ:IDXX
Country US
Market Cap 41.7B USD
Operating Margin
30%

Profitability Report

View the profitability report to see the full profitability analysis for Edwards Lifesciences Corp.

Full Profitability Report

See Also

Summary
EW intrinsic value, competitors valuation, and company profile.
DCF Valuation
EW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EW stock valuation using valuation multiples.
Wall Street Estimates
EW price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
28.7%
=
Operating Profit
1.8B
/
Revenue
6.1B
What is the Operating Margin of Edwards Lifesciences Corp?

Based on Edwards Lifesciences Corp's most recent financial statements, the company has Operating Margin of 28.7%.

ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.